These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

445 related articles for article (PubMed ID: 31420036)

  • 1. Serum BDNF and GDNF in Chinese male patients with deficit schizophrenia and their relationships with neurocognitive dysfunction.
    Tang X; Zhou C; Gao J; Duan W; Yu M; Xiao W; Zhang X; Dong H; Wang X; Zhang X
    BMC Psychiatry; 2019 Aug; 19(1):254. PubMed ID: 31420036
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cognitive impairment in first-episode drug-naïve patients with schizophrenia: Relationships with serum concentrations of brain-derived neurotrophic factor and glial cell line-derived neurotrophic factor.
    Xiao W; Ye F; Liu C; Tang X; Li J; Dong H; Sha W; Zhang X
    Prog Neuropsychopharmacol Biol Psychiatry; 2017 Jun; 76():163-168. PubMed ID: 28342945
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Brain-derived neurotrophic factor is associated with cognitive impairments in first-episode and chronic schizophrenia.
    Yang Y; Liu Y; Wang G; Hei G; Wang X; Li R; Li L; Wu R; Zhao J
    Psychiatry Res; 2019 Mar; 273():528-536. PubMed ID: 30710808
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diverse glial cell line-derived neurotrophic factor (GDNF) support between mania and schizophrenia: a comparative study in four major psychiatric disorders.
    Tunca Z; Kıvırcık Akdede B; Özerdem A; Alkın T; Polat S; Ceylan D; Bayın M; Cengizçetin Kocuk N; Şimşek S; Resmi H; Akan P
    Eur Psychiatry; 2015 Feb; 30(2):198-204. PubMed ID: 25543333
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The roles of brain-derived neurotrophic factor (BDNF) and glial cell line-derived neurotrophic factor (GDNF) in predicting treatment remission in a Chinese Han population with generalized anxiety disorder.
    Shen Z; Zhu J; Yuan Y; Ren L; Qian M; Lin M; Cai M; Zhang Z; Shen X
    Psychiatry Res; 2019 Jan; 271():319-324. PubMed ID: 30529313
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alterations in BDNF (brain derived neurotrophic factor) and GDNF (glial cell line-derived neurotrophic factor) serum levels in bipolar disorder: The role of lithium.
    Tunca Z; Ozerdem A; Ceylan D; Yalçın Y; Can G; Resmi H; Akan P; Ergör G; Aydemir O; Cengisiz C; Kerim D
    J Affect Disord; 2014 Sep; 166():193-200. PubMed ID: 25012431
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum nerve growth factor beta, brain- and glial-derived neurotrophic factor levels and psychopathology in unmedicated patients with schizophrenia.
    Chu CS; Chu CL; Wu CC; Lu T
    J Chin Med Assoc; 2018 Jun; 81(6):577-581. PubMed ID: 29366645
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between serum levels of glial cell-line derived neurotrophic factor and attention deficits in schizophrenia.
    Niitsu T; Shirayama Y; Matsuzawa D; Shimizu E; Hashimoto K; Iyo M
    Neurosci Lett; 2014 Jul; 575():37-41. PubMed ID: 24861509
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Associations of serum brain-derived neurotrophic factor with cognitive impairments and negative symptoms in schizophrenia.
    Niitsu T; Shirayama Y; Matsuzawa D; Hasegawa T; Kanahara N; Hashimoto T; Shiraishi T; Shiina A; Fukami G; Fujisaki M; Watanabe H; Nakazato M; Asano M; Kimura S; Hashimoto K; Iyo M
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Dec; 35(8):1836-40. PubMed ID: 21930178
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cognitive impairments and low BDNF serum levels in first-episode drug-naive patients with schizophrenia.
    Man L; Lv X; Du XD; Yin G; Zhu X; Zhang Y; Soares JC; Yang XN; Chen X; Zhang XY
    Psychiatry Res; 2018 May; 263():1-6. PubMed ID: 29482040
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Establishment of diagnostic model for schizophrenia based on neurotrophic factor and other biomarkers].
    Pang LJ; Li X; Yuan XX; Hei GR; Zhang LY; Wang SY; Chen YS; Song PL; Song XQ
    Zhonghua Yi Xue Za Zhi; 2023 May; 103(17):1310-1315. PubMed ID: 37150680
    [No Abstract]   [Full Text] [Related]  

  • 12. Neurocognitive Impairments in Deficit and Non-Deficit Schizophrenia and Their Relationships with Symptom Dimensions and Other Clinical Variables.
    Yu M; Tang X; Wang X; Zhang X; Zhang X; Sha W; Yao S; Shu N; Zhang X; Zhang Z
    PLoS One; 2015; 10(9):e0138357. PubMed ID: 26381645
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decreased Neurotrophic Support is Associated with Cognitive Decline in Non-Demented Subjects.
    Forlenza OV; Miranda AS; Guimar I; Talib LL; Diniz BS; Gattaz WF; Teixeira AL
    J Alzheimers Dis; 2015; 46(2):423-9. PubMed ID: 25737042
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Brain-derived neurotrophic factor as a biomarker for cognitive recovery in acute schizophrenia: 12-week results from a prospective longitudinal study.
    Zhang Y; Fang X; Fan W; Tang W; Cai J; Song L; Zhang C
    Psychopharmacology (Berl); 2018 Apr; 235(4):1191-1198. PubMed ID: 29392373
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum BDNF levels, glycolipid metabolism in deficit schizophrenia: A case-control study.
    Zhu X; Chen D; Xiu M; Li S; Zhang XY
    Asian J Psychiatr; 2022 Mar; 69():103003. PubMed ID: 34999534
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum brain-derived neurotrophic factor, glial-derived neurotrophic factor, nerve growth factor, and neurotrophin-3 levels in children with attention-deficit/hyperactivity disorder.
    Bilgiç A; Toker A; Işık Ü; Kılınç İ
    Eur Child Adolesc Psychiatry; 2017 Mar; 26(3):355-363. PubMed ID: 27561780
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Eye movement characteristics in male patients with deficit and non-deficit schizophrenia and their relationships with psychiatric symptoms and cognitive function.
    Zhang L; Zhang X; Fang X; Zhou C; Wen L; Pan X; Zhang F; Chen J
    BMC Neurosci; 2021 Nov; 22(1):70. PubMed ID: 34819034
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationships between serum brain-derived neurotrophic factor, plasma catecholamine metabolites, cytokines, cognitive function and clinical symptoms in Japanese patients with chronic schizophrenia treated with atypical antipsychotic monotherapy.
    Hori H; Yoshimura R; Katsuki A; Atake K; Igata R; Konishi Y; Nakamura J
    World J Biol Psychiatry; 2017 Aug; 18(5):401-408. PubMed ID: 27409727
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum brain-derived neurotrophic factor and glial cell-derived neurotrophic factor in patients with first-episode depression at different ages.
    He X; Song J; Gao H; Li Z; Wang X; Zeng Q; Xiao Y; Feng J; Zhou D; Wang G
    Int J Psychiatry Clin Pract; 2023 Jun; 27(2):118-126. PubMed ID: 35980319
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A positive correlation between serum levels of mature brain-derived neurotrophic factor and negative symptoms in schizophrenia.
    Niitsu T; Ishima T; Yoshida T; Hashimoto T; Matsuzawa D; Shirayama Y; Nakazato M; Shimizu E; Hashimoto K; Iyo M
    Psychiatry Res; 2014 Feb; 215(2):268-73. PubMed ID: 24377440
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.